Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Terry B Strom

Showing results (11-20 of 111) with videos related to

Pageof 12
Sort By:
Journal of the American Society of Nephrology : JASN|August 4, 2009
Recently discovered T cell subsets cannot keep their commitmentsTerry B Strom, Maria Koulmanda
Nature Reviews. Nephrology|October 2, 2013
Transplantation: a new molecular approach to the diagnosis of acute rejectionAnil Chandraker, Terry B Strom
Current Opinion in Immunology|October 23, 2008
Cytokine related therapies for autoimmune diseaseTerry B Strom, Maria Koulmanda
Kidney International|March 13, 2003
A refined understanding of immunosuppressives and cancer riskTerry B Strom, Vikas P Sukhatme
Journal of Hepatology|November 3, 2004
Immunological tolerance and liver transplantationAlberto Sánchez-Fueyo, Terry B Strom
Gastroenterology|November 16, 2010
Immunologic basis of graft rejection and tolerance following transplantation of liver or other solid organsAlberto Sánchez-Fueyo, Terry B Strom
F1000 Biology Reports|February 2, 2011
Creating transplant tolerance by taming adverse intragraft innate immunityDusan Hanidziar, Maria Koulmanda, Terry B Strom
Transplantation|May 9, 2009
TIM-1: a new player in transplant immunityChristophe Mariat, Nicolas Degauque, Terry B Strom
Advances in Experimental Medicine and Biology|October 11, 2014
A20--a biomarker of allograft outcome: a showcase in kidney transplantationGabor Bodonyi-Kovacs, Terry B Strom, Prabhakar Putheti
Journal of the American Society of Nephrology : JASN|April 22, 2004
Allogeneic stem cell-derived "repair unit" therapy and the barriers to clinical deploymentTerry B Strom, Loren J Field, Manfred Ruediger
Pageof 12

Showing results (11-20 of 111) with videos related to

Sort By:
Pageof 12
Journal of the American Society of Nephrology : JASN|August 4, 2009
Recently discovered T cell subsets cannot keep their commitmentsTerry B Strom, Maria Koulmanda
Nature Reviews. Nephrology|October 2, 2013
Transplantation: a new molecular approach to the diagnosis of acute rejectionAnil Chandraker, Terry B Strom
Current Opinion in Immunology|October 23, 2008
Cytokine related therapies for autoimmune diseaseTerry B Strom, Maria Koulmanda
Kidney International|March 13, 2003
A refined understanding of immunosuppressives and cancer riskTerry B Strom, Vikas P Sukhatme
Journal of Hepatology|November 3, 2004
Immunological tolerance and liver transplantationAlberto Sánchez-Fueyo, Terry B Strom
Gastroenterology|November 16, 2010
Immunologic basis of graft rejection and tolerance following transplantation of liver or other solid organsAlberto Sánchez-Fueyo, Terry B Strom
F1000 Biology Reports|February 2, 2011
Creating transplant tolerance by taming adverse intragraft innate immunityDusan Hanidziar, Maria Koulmanda, Terry B Strom
Transplantation|May 9, 2009
TIM-1: a new player in transplant immunityChristophe Mariat, Nicolas Degauque, Terry B Strom
Advances in Experimental Medicine and Biology|October 11, 2014
A20--a biomarker of allograft outcome: a showcase in kidney transplantationGabor Bodonyi-Kovacs, Terry B Strom, Prabhakar Putheti
Journal of the American Society of Nephrology : JASN|April 22, 2004
Allogeneic stem cell-derived "repair unit" therapy and the barriers to clinical deploymentTerry B Strom, Loren J Field, Manfred Ruediger
Pageof 12